JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online February 17, 2009, 10.2967/jnumed.108.055665
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Range, F. T.
Right arrow Articles by Schäfers, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Range, F. T.
Right arrow Articles by Schäfers, M. A.

Myocardial Perfusion in Nonischemic Dilated Cardiomyopathy With and Without Atrial Fibrillation

Felix T. Range*,1–3, Matthias Paul*,2,3, Klaus P. Schäfers1, Tayfun Acil2, Peter Kies1,3, Sven Hermann1, Otmar Schober1, Günter Breithardt2, Thomas Wichter2,3 and Michael A. Schäfers1,3

1 Department of Nuclear Medicine, University of Münster, Münster, Germany; 2 Department of Cardiology and Angiology, University of Münster, Münster, Germany; and 3 Interdisciplinary Centre of Clinical Research (IZKF), University of Münster, Münster, Germany


Figure 1
View larger version (13K):
[in this window]
[in a new window]

 
FIGURE 1.  MBF in DCM/AF, DCM/SR, and controls as measured by H215O PET at baseline and under adenosine infusion (ADO). MBF at baseline has been corrected for rate–pressure product.

 

Figure 2
View larger version (15K):
[in this window]
[in a new window]

 
FIGURE 2.  Coronary flow reserve (CFR) calculated from MBF under adenosine infusion divided by baseline MBF corrected for rate–pressor product in DCM/AF, DCM/SR, and controls as determined by H215O PET.

 

Figure 3
View larger version (13K):
[in this window]
[in a new window]

 
FIGURE 3.  CVR at baseline and under adenosine administration (ADO) in DCM/AF, DCM/SR, and controls.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2009 by the Society of Nuclear Medicine.